Dementia as a policy priority - John Gallacher: Real world data supporting regulatory and health technology assessments: the findings of the ROADMAP project
18 Dec 2018
P28.1 Real-world data availability across Europe: What data are present, missing and heterogeneity of data collected? Glòria Garcia: Developing the Data Cube
18 Dec 2018
P28.2 Real-world data availability across Europe: What data are present, missing and heterogeneity of data collected? Johan van der Lei: Challenges to fill in the Data Cube, differences across data sources
18 Dec 2018
P28.3 Real-world data availability across Europe: What data are present, missing and heterogeneity of data collected? Antje Hottgenroth: Industry perspective on use and future development of ROADMAPs Data Cube
18 Dec 2018
P20.1 Regulatory and HTA perspectives on real-world data in AD: Future of prospective collection and further research. Diana O’Rourke
18 Dec 2018
P20.2 Regulatory and HTA perspectives on real-world data in AD: Future of prospective collection and further research. Catherine Reed
18 Dec 2018
P12.1. Ana Diaz (Luxembourg) & Jayne Goodrick (EWGPWD): The involvement of the European Working Group of People With Dementia in the ethics work of ROADMAP
09 Jan 2019
P12.2 Ethics challenges for Alzheimer’s disease research and practice using real-world data. Zuzanna Angehrn: Ethical and social implications of using predictive modelling for Alzheimer´s disease prevention
18 Dec 2018
P12.3 Ethics challenges for Alzheimer’s disease research and practice using real-world data. Alex McKeown: Ethical issues in outcome prioritisation in Alzheimer’s disease treatment
18 Dec 2018
P4.1 Disease outcomes: What matters to whom as AD progresses? Relevant outcomes in disease progression. Claire Tochel: Outcome definition in ROADMAP
18 Dec 2018
P4.2 Disease outcomes: What matters to whom as AD progresses? Relevant outcomes in disease progression Christophe Bintener and Helen Rochford-Brennan (EWGPWD): The involvement of the European Working Group of People with Dementia in the outcomes work of ROADMAP
18 Dec 2018
P4.3 Disease outcomes: What matters to whom as AD progresses? Relevant outcomes in disease progression Michael Smith: Important outcomes of Alzheimer’s disease from the perspective of people with the disease, their supporters & health professionals
18 Dec 2018
P4.4 Disease outcomes: What matters to whom as AD progresses? Relevant outcomes in disease progression. Tania Dussey: Policy and industry reflections on ROADMAPs outcome definition work
09 Jan 2019
Sarah Baumeister introducing DPUKs role in EPAD and ROADMAP
30 Jul 2018
BD4BO: the transformational potential of Big Data for the benefit of patients and society
10 Jul 2018
Meet Carlos Diaz - ROADMAP Project Manager introducing challenges and strengths from a management perspective
15 May 2018
Meet John Gallacher - ROADMAP Project Coordinator providing a progress update at General Assembly Meeting
07 May 2018
Meet Alastair Gray - Health Economics team co-lead
26 Apr 2018
Has the Time for Big/Real World Data Finally Arrived?
05 Apr 2018
XI Annual Conference of Biomedical Research Technology Platforms
05 Mar 2018
Review on disease progression models in AD, Michele Potashman
01 Mar 2018
Christin Bexelius - Outcome Definition team co-lead
08 Jan 2018
Principal Investigator and Project Coordinator John Gallacher introducing the ROADMAP project
16 Oct 2017
27 Alzheimer Europe Conference Lilly Special Symposium - PI Catherine Reed: ROADMAP
04 Oct 2017
Using big data to define and validate real world outcomes in Alzheimer’s disease
16 Jun 2016
